1. Significance of lung biopsy for the definitive diagnosis of lung nodules in breast cancer patients
   Kazuo Matsuura et al, 2017, Molecular and Clinical Oncology CrossRef
2. Cancer nanomedicine: Recent developments in drug delivery systems and strategies to overcome eventual barriers to achieve a better outcome
   Jeferson Gustavo Henn et al, 2024, Journal of Drug Delivery Science and Technology CrossRef
3. Optimal body mass index cut‑point for predicting recurrence‑free survival in patients with non‑muscle‑invasive urothelial carcinoma of bladder
   Satoru Yonekura et al, 2018, Oncology Letters CrossRef
4. Progesterone receptor status modifies the association between body mass index and prognosis in women diagnosed with estrogen receptor positive breast cancer
   Thiphavone Oudanonh et al, 2020, International Journal of Cancer CrossRef
5. Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: A systematic review and meta-analysis
   Elizabeth M. Salvo et al, 2021, The Breast CrossRef
6. Genome-wide association study identifies a role for the progesterone receptor in benign prostatic hyperplasia risk
   Weiqiang Li et al, 2021, Prostate Cancer and Prostatic Diseases CrossRef
7. Association of Obesity With Breast Cancer Outcome in Relation to Cancer Subtypes: A Meta-Analysis
   Ana Elisa Lohmann et al, 2021, JNCI: Journal of the National Cancer Institute CrossRef
8. The impact of BMI on breast cancer – an updated systematic review and meta-analysis
   Nikolaos Tzenios et al, 2024, Medicine CrossRef
9. Associations of adiposity and weight change with recurrence and survival in breast cancer patients: a systematic review and meta-analysis
   Yuanjie Pang et al, 2022, Breast Cancer CrossRef
10. Postdiagnosis body fatness, weight change and breast cancer prognosis: Global Cancer Update Program (CUP global) systematic literature review and meta‐analysis
    Doris S.M. Chan et al, 2023, International Journal of Cancer CrossRef